Skip to main content

Day: November 4, 2021

Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2021 

 Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2021  (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)   Market : NYSE Euronext Paris ISIN Code: FR 0010417345DateTotal number of shares Total number of voting rights10/31/2021 55,011,687Total gross of voting rights: 55,011,687Total net* of voting rights: 54,910,187* Total net = total number of voting rights attached to shares – shares without voting rights        AttachmentPDF Version

Continue reading

Galecto Reports Third Quarter Operating and Financial Results

Announces clinical collaboration with Roche for first line NSCLC Remains on track with clinical data milestone timing BOSTON, Nov. 04, 2021 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer, today announced its operating and financial results for the quarter ended September 30, 2021. “The third quarter continued to show strong execution by the Galecto team, as we initiated enrollment in two separate Phase 2 trials with different mechanisms of action – one focused on our oral galectin-3 inhibitor, GB1211, for the treatment of liver cirrhosis, and the other focused on our collagen-cross linking enzyme, LOXL2, inhibitor, GB2064, for the treatment of myelofibrosis. We recently completed enrollment in Part 1 of the liver cirrhosis...

Continue reading

FDA Awards Breakthrough Device Designation to the ReWalk ReBoot Soft Exo-Suit

Soft exoskeleton device for stroke survivors will be for use at home and in the community to help with walking and mobility MARLBOROUGH, Mass., Nov. 04, 2021 (GLOBE NEWSWIRE) — ReWalk Robotics, Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a leading global manufacturer of robotic medical devices for individuals with lower limb disabilities, today announced its ReBoot device has been granted designation as a Breakthrough Device by the Food and Drug Administration (FDA). The ReBoot is a lightweight, battery-powered orthotic exo-suit intended to assist ambulatory functions in individuals with reduced ankle function related to neurological injuries, such as stroke. The ReBoot is a customizable personalized device intended for home and community use. It is a sister product to the ReStore device, which received...

Continue reading

IntelGenx to Report Third Quarter 2021 Financial Results on November 11, 2021 – Conference Call to Follow

SAINT LAURENT, Quebec, Nov. 04, 2021 (GLOBE NEWSWIRE) — IntelGenx Technologies Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it will release its third quarter 2021 financial results after market close on Thursday, November 11, 2021. An accompanying conference call will be hosted by Dr. Horst G. Zerbe, Chief Executive Officer, and Mr. Andre Godin, President and Chief Financial Officer, to discuss the results and provide a business update. Details of the conference call and webcast are below:Third Quarter 2021 Results Conference Call Details:   Date: Thursday, November 11, 2021   Time:  4:30 p.m. ET   Live Call:  1-888-506-0058 (Canada and the United States)  1-973-528-0135 (International)   Access Code: 995615The call will also be broadcast live...

Continue reading

Mandalay Resources Provides Target Release Date for Third Quarter 2021 Financial Results and Conference Call

TORONTO, Nov. 04, 2021 (GLOBE NEWSWIRE) — Mandalay Resources Corporation (“Mandalay” or “the Company”) (TSX: MND, OTCQB: MNDJF) announces that its third quarter 2021 financial results will be released after market close on November 09, 2021, followed by a conference call with Dominic Duffy, President and Chief Executive Officer of Mandalay for investors and analysts on November 10, 2021, at 8:00 AM (Toronto time). Analysts and interested investors are invited to participate using the following dial-in numbers:Participant Number (Toll free): (800) 582-0984Participant Number: (212) 231-2912Conference ID: 13724968A replay of the conference call will be available until 11:59 PM (Toronto time), November 24, 2021, and can be accessed using the following dial-in number:Encore Toll Free Dial-in Number: (877) 660-6853Encore...

Continue reading

AgileThought Announces Third Quarter 2021 Earnings Release and Conference Call Date

DALLAS, Nov. 04, 2021 (GLOBE NEWSWIRE) — AgileThought, Inc. (“AgileThought” or the “Company”) (NASDAQ: AGIL), a global provider of digital transformation services, custom software development, and next generation technologies, today announced that it will release its third quarter 2021 financial results after the market close on Monday, November 15, 2021. The Company will host a conference call to discuss its financial results at 5:00 p.m. Eastern Time that same day. Those wishing to participate via webcast should access the call through the Company’s Investor Relations website at https://ir.agilethought.com/. Those wishing to participate via telephone may dial in at 1-877-407-9039 (USA) or 1-201-689-8470 (International). The conference call replay will be available via webcast through the Company’s Investor Relations website....

Continue reading

Host Hotels & Resorts Provides Updated Investor Presentation for Nareit’s Virtual REITworld 2021 Annual Conference (November 9-11)

BETHESDA, Md., Nov. 04, 2021 (GLOBE NEWSWIRE) — Host Hotels & Resorts, Inc. (NASDAQ: HST), the nation’s largest lodging real estate investment trust (the “Company”), today provided an updated investor presentation for Nareit’s Virtual REITworld 2021 Annual Conference (November 9-11). The investor presentation can be found on the Investor Relations section on the company’s website at https://www.hosthotels.com/investor-relations/investor-presentation. About Host Hotels & Resorts Host Hotels & Resorts, Inc. is an S&P 500 company and is the largest lodging real estate investment trust and one of the largest owners of luxury and upper-upscale hotels. The Company currently owns 75 properties in the United States and five properties internationally totaling approximately 45,400 rooms. The Company...

Continue reading

Safeguard Scientifics Announces Third Quarter 2021 Financial Results

Successful Completion of $39mm Self-tender Offer Conference call and webcast on November 4, 2021 at 5 p.m. ET RADNOR, Pa., Nov. 04, 2021 (GLOBE NEWSWIRE) — Safeguard Scientifics, Inc. (NYSE:SFE) (“Safeguard” or the “Company”) today announced financial results for the three and nine months ended September 30, 2021. HIGHLIGHTSCapital ReturnOn October 7, 2021, Safeguard completed a modified Dutch auction self-tender that resulted in the repurchase of 4.3 million shares of its common stock at a cost of $9.00 per share or a total of $38.7 million.Exits & DeploymentsFlashtalking was acquired by Mediaocean resulting in $44.8 million of cash proceeds upon the closing. As a result of this exit, Safeguard reported a gain of $32.3 million. Safeguard funded $1.7 million to Aktana as part of a larger financing.Safeguard...

Continue reading

Doman Building Materials Group Ltd. Increases Quarterly Dividend and Announces Third Quarter 2021 Financial Results

NOT FOR RELEASE OR DISSEMINATION INTO THE UNITED STATES Q3 2021 Financial Highlights(1):Revenues increased 32.4% to $625.3 million Gross Margin at 12.9% Adjusted EBITDA(3) amounted to $34.5 million Net Earnings amounted to $7.7 million Quarterly dividend of $0.12 per share paid on October 15, 2021(4) and the Board of Directors increases quarterly dividend to $0.14 per share effective the fourth quarter of 2021VANCOUVER, British Columbia, Nov. 04, 2021 (GLOBE NEWSWIRE) — Doman Building Materials Group Ltd. (“Doman” or “the Company”) (TSX:DBM; DBM.NT.A) announced today its third quarter 2021 financial results(1) for the period ended September 30, 2021. For the three-month period ended September 30, 2021(1), consolidated revenues increased by 32.4% to $625.3 million when compared to $472.2 million in the same period in 2020. The...

Continue reading

Cross Keys Capital Advises Retina Associates of Utah, P.C., on Its Partnership with Retina Consultants of America

Fort Lauderdale, FL, Nov. 04, 2021 (GLOBE NEWSWIRE) — Cross Keys Capital, a leading investment bank to physician group practices and healthcare service and technology companies, is pleased to announce it has served as the exclusive sell-side M&A advisor to Retina Associates of Utah, P.C. (RAU), in its partnership with Retina Consultants of America (RCA), a portfolio company of Webster Equity Partners. The Cross Keys team included Jeanne Proia, Managing Director, and Patrick Foley, Senior Analyst, who both have extensive experience with retina transactions. RAU is the largest group of retina specialists in the Intermountain West and provides comprehensive medical and surgical treatment for disorders of the retina, macula, and vitreous. The practice is led by five partner physicians and includes six board-certified and fellowship-trained...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.